Features, pricing, ratings, and pros and cons, compared head to head.
360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform tool by 360 Security Group (Qihoo 360). CloudDefense.AI QINA is a commercial cloud-native application protection platform tool by CloudDefense.AI. Compare features, ratings, integrations, and community reviews side by side to find the best endpoint protection platform fit for your security stack. Independent and vendor-neutral: our scores and rankings are earned, never bought — sponsored placement is always labeled.
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats. Security teams at mid-market and enterprise organizations need CloudDefense.AI QINA if they're tired of stitching together separate tools for code, container, and cloud security. The sub-60 second CI/CD scan completion and AI-powered reachability analysis actually reduce alert fatigue instead of just claiming to, and native support for SAST, DAST, API testing, and CSPM means you're not maintaining six different vendor relationships. Skip this if your team lacks the infrastructure maturity to act on multi-layered findings quickly; QINA will surface real vulnerabilities across your entire stack, but weak remediation workflows will leave you buried.
Based on our analysis of core features, integrations, company size fit, deployment model, here is our conclusion:
360 High-Risk Vulnerability Immunization Tool V2.0
Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.
Security teams at mid-market and enterprise organizations need CloudDefense.AI QINA if they're tired of stitching together separate tools for code, container, and cloud security. The sub-60 second CI/CD scan completion and AI-powered reachability analysis actually reduce alert fatigue instead of just claiming to, and native support for SAST, DAST, API testing, and CSPM means you're not maintaining six different vendor relationships. Skip this if your team lacks the infrastructure maturity to act on multi-layered findings quickly; QINA will surface real vulnerabilities across your entire stack, but weak remediation workflows will leave you buried.
Tool that immunizes Windows systems against critical vulnerabilities
AI-powered CNAPP combining SAST, DAST, API, SCA, CSPM, CWPP, and CIEM capabilities
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPExplore more tools in this category or create a security stack with your selections.
Common questions about comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs CloudDefense.AI QINA for your endpoint protection platform needs.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360)..
CloudDefense.AI QINA: AI-powered CNAPP combining SAST, DAST, API, SCA, CSPM, CWPP, and CIEM capabilities. built by CloudDefense.AI..
Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.
360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). CloudDefense.AI QINA is developed by CloudDefense.AI. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
360 High-Risk Vulnerability Immunization Tool V2.0 and CloudDefense.AI QINA serve similar Endpoint Protection Platform use cases. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox